Ignite Creation Date:
2025-12-25 @ 3:24 AM
Ignite Modification Date:
2026-05-28 @ 7:59 AM
Study NCT ID:
NCT01607905
Status:
COMPLETED
Last Update Posted:
2023-01-26
First Post:
2012-05-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor Cancer
Sponsor:
Karyopharm Therapeutics Inc
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Solid Tumor | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Melanoma | View |
| None | Colorectal cancer | View |
| None | Gynecological cancer | View |
| None | Castrate-resistant Prostate Cancer | View |
| None | Other solid tumors | View |
| None | Glioblastoma multiforme | View |
| None | Adenocarcinoma | View |
| None | Selinexor | View |
| None | KPT-330 | View |
| None | Squamous Cell Carcinoma | View |